chr4-75521784-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000311638.7(THAP6):c.337G>A(p.Val113Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000577 in 1,613,056 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000311638.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
THAP6 | NM_144721.6 | c.337G>A | p.Val113Ile | missense_variant | 4/5 | ENST00000311638.7 | NP_653322.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
THAP6 | ENST00000311638.7 | c.337G>A | p.Val113Ile | missense_variant | 4/5 | 1 | NM_144721.6 | ENSP00000309007 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151990Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000124 AC: 31AN: 250932Hom.: 1 AF XY: 0.000155 AC XY: 21AN XY: 135674
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1461066Hom.: 2 Cov.: 32 AF XY: 0.0000839 AC XY: 61AN XY: 726854
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151990Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74242
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2022 | The c.337G>A (p.V113I) alteration is located in exon 4 (coding exon 3) of the THAP6 gene. This alteration results from a G to A substitution at nucleotide position 337, causing the valine (V) at amino acid position 113 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at